Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2008The IL-3/IL-5/GM-CSF common beta receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammationAsquith, K.; Ramshaw, H.; Hansbro, P.; Beagley, K.; Lopez, A.; Foster, P.
200914-3-3:Shc scaffolds integrate phosphoserine and phosphotyrosine signaling to regulate phosphatidylinositol 3-kinase activation and cell survivalBarry, E.; Felquer, F.; Powell, J.; Biggs, L.; Stomski, F.; Urbani, A.; Ramshaw, H.; Hoffmann, P.; Wilce, M.; Grimbaldeston, M.; Lopez, A.; Guthridge, M.
2007The Shc-binding site of the β[c] subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesisRamshaw, H.; Guthridge, M.; Stomski, F.; Barry, E.; Ooms, L.; Mitchell, C.; Begley, C.; Lopez, A.
2009Sphingosine kinase regulates the rate of endothelial progenitor cell differentiationBonder, C.; Sun, W.; Matthews, T.; Cassano, C.; Li, X.; Ramshaw, H.; Pitson, S.; Lopez, A.; Coates, P.; Proia, R.; Vadas, M.; Gamble, J.
2004The phosphoserine-585-dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-kB and induction of bcl-2Guthridge, M.; Barry, E.; Felquer, F.; Mc Clure, B.; Stomski, F.; Ramshaw, H.; Lopez, A.
2002The development of cytokine receptor antagonists as potential therapeutic agents for the myeloproliferative disordersRamshaw, H.; Lopez, A.; Bardy, P.
2002Chronic myelomonocytic leukemia requires granulocyte-macrophage colony-stimulating factor for growth in vitro and in vivoRamshaw, H.; Bardy, P.; Lee, M.; Lopez, A.